Showing results (151-160 of 177) with videos related to

Sort By:
Pageof 18
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 23, 2020
Rational design and characterisation of a linear cell penetrating peptide for non-viral gene deliveryEmma M McErlean, Monika Ziminska, Cian M McCrudden, et al.
International Journal of Pharmaceutics|June 8, 2024
Systemic delivery of bictegravir and tenofovir alafenamide using dissolving microneedles for HIV preexposure prophylaxisChunyang Zhang, Yu Wu, Aaron R J Hutton, et al.
Advanced Healthcare Materials|March 7, 2019
Design, Formulation, and Evaluation of Novel Dissolving Microarray Patches Containing Rilpivirine for Intravaginal DeliveryMaelíosa T C Mc Crudden, Eneko Larrañeta, Annie Clark, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 21, 2024
Synthesis and characterisation of a nucleotide based pro-drug formulated with a peptide into a nano-chemotherapy for colorectal cancerJordan J Wilson, Lindsey Bennie, Olga Eguaogie, et al.
Molecular Pharmaceutics|March 9, 2016
Potentiating the Anticancer Properties of Bisphosphonates by Nanocomplexation with the Cationic Amphipathic Peptide, RALAAshley S Massey, Sreekanth Pentlavalli, Richard Cunningham, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 18, 2016
Transcending epithelial and intracellular biological barriers; a prototype DNA delivery deviceJoanne McCaffrey, Cian M McCrudden, Ahlam A Ali, et al.
Nanomedicine (London, England)|July 28, 2016
Preclinical evaluation of gold-DTDTPA nanoparticles as theranostic agents in prostate cancer radiotherapyKarl T Butterworth, James R Nicol, Mihaela Ghita, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 8, 2022
HPLC-MS method for simultaneous quantification of the antiretroviral agents rilpivirine and cabotegravir in rat plasma and tissuesInken K Ramöller, Marco T A Abbate, Lalitkumar K Vora, et al.
Pageof 18